Aflibercept biosimilar SB15 improved retinal anatomy while preserving vision in both treatment-naïve and switching patients with nAMD, RVO, and DME. Aflibercept 2 mg biosimilar SB15 (Afilivu; Samsung ...
Real-world natalizumab biosimilar switching preserved relapsing-remitting MS outcomes but lowered treatment satisfaction, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results